If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.71    0.11 (6.87%)
Bid:
1.61
Ask:
1.72
Spread: 0.11 (6.832%)
Market Cap: £34.31m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Holding(s) in Company

16 Sep 2015 16:30

RNS Number : 2516Z
Quintain Estates & Development PLC
16 September 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Quintain Estates & Development Plc

GB0007184442

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

n/a

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

n/a

An event changing the breakdown of voting rights

n/a

Other (please specify):

n/a

3. Full name of person(s) subject to thenotification obligation: iii

UBS Investment Bank

UBS Group AG

4. Full name of shareholder(s)  (if different from 3.):iv

UBS AG London Branch

UBS Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

14 September 2015

6. Date on which issuer notified:

16 September 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

7%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct xi

Indirect xii

Direct

Indirect

GB0007184442

36,535,275

36,535,275

-

-

37,834,447

-

7.19%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

-

-

-

-

-

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

-

-

-

-

 

-

Nominal

Delta

-

-

Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,834,447

7.19%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

UBS Group AG is a group holding company for UBS Investment Bank business. Voting rights

are held through its controlled undertakings as set out below.

 

UBS AG:

- directly through its branches: UBS AG London Branch - 35,534,192 (6.75%); and

- indirectly through its subsidiaries: UBS Limited - 2,300,255 (0.44%)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Konstantina Georgaki / Zuzana Görögová

15. Contact telephone number:

+41 44 239 4071

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMMGMLMVLGKZM
Date   Source Headline
24th May 20127:02 amRNSBoard Changes
24th May 20127:00 amRNSFinal Results - Part 2
24th May 20127:00 amRNSFinal Results - Part 1
23rd May 20127:00 amRNSiQ Fund agrees further £70m financing with M&G
15th May 20123:23 pmRNSDirector/PDMR Shareholding
14th May 201210:52 amRNSNotice of Preliminary Results
4th May 20124:02 pmRNSDirector/PDMR Shareholding
30th Apr 201210:35 amRNSBlocklisting Interim Review
3rd Apr 20127:00 amRNSiQ Fund Agrees £158 million refinancing
2nd Apr 201210:32 amRNSTotal Voting Rights
29th Mar 20127:00 amRNSSale of Emersons Green
23rd Mar 201210:58 amRNSDirector/PDMR Shareholding
29th Feb 20124:54 pmRNSTotal Voting Rights
28th Feb 20127:00 amRNSAcquisition
20th Feb 20121:32 pmRNSHolding(s) in Company
16th Feb 20122:44 pmRNSDirectorate Change
2nd Feb 20127:00 amRNSInterim Management Statement
1st Feb 20122:30 pmRNSNotice of IMS
31st Jan 20125:44 pmRNSTotal Voting Rights
17th Jan 201211:04 amRNSDirector/PDMR Shareholding
29th Dec 201110:22 amRNSTotal Voting Rights
13th Dec 20113:33 pmRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSHalf Yearly Report
22nd Nov 20112:55 pmRNSHolding(s) in Company
17th Nov 20117:00 amRNSDisposal
14th Nov 20112:20 pmRNSDirector/PDMR Shareholding
4th Nov 20114:04 pmRNSHolding(s) in Company
1st Nov 201110:27 amRNSBlocklisting Interim Review
20th Oct 20112:43 pmRNSNotice of Results
18th Oct 201110:03 amRNSAdditional Listing
13th Oct 20112:34 pmRNSDirector/PDMR Shareholding
13th Oct 20117:00 amRNSDisposal
11th Oct 201110:03 amRNSHolding(s) in Company
10th Oct 20111:10 pmRNSHolding(s) in Company
22nd Sep 20112:30 pmRNSDirector/PDMR Shareholding
21st Sep 20118:30 amRNSHolding(s) in Company
19th Sep 20111:53 pmRNSHolding(s) in Company
16th Sep 20114:57 pmRNSDirector/PDMR Shareholding
6th Sep 20114:31 pmRNSAnnual Information Update
5th Sep 20114:01 pmRNSResult of AGM
31st Aug 20115:20 pmRNSHolding(s) in Company
16th Aug 20111:09 pmRNSDirector/PDMR Shareholding
11th Aug 201110:26 amRNSNotice of AGM
10th Aug 20117:00 amRNSInterim Management Statement
1st Aug 20113:14 pmRNSNotice of IMS
14th Jul 201112:08 pmRNSAnnual Financial Report
13th Jul 20113:10 pmRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSDirectorate Change
14th Jun 201111:18 amRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.